- Home
- FTHM vs PASG Comparison
FTHM vs PASG Comparison
Compare FTHM & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | PASG |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 28.6M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FTHM | PASG |
|---|---|---|
| Price | $0.99 | $11.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.50 | ★ $34.50 |
| AVG Volume (30 Days) | ★ 103.0K | 50.9K |
| Earning Date | 11-11-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $421,612,000.00 | N/A |
| Revenue This Year | $30.07 | N/A |
| Revenue Next Year | $14.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.78 | N/A |
| 52 Week Low | $0.65 | $5.12 |
| 52 Week High | $3.37 | $20.20 |
Technical Indicators
Market Signals| Indicator | FTHM | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 63.61 |
| Support Level | $0.86 | $9.56 |
| Resistance Level | $1.15 | $11.50 |
| Average True Range (ATR) | 0.09 | 1.04 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 29.25 | 75.99 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.